Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 210

Similar articles for PubMed (Select 22542002)

1.

Broad neutralization of wild-type dengue virus isolates following immunization in monkeys with a tetravalent dengue vaccine based on chimeric yellow fever 17D/dengue viruses.

Barban V, Munoz-Jordan JL, Santiago GA, Mantel N, Girerd Y, Gulia S, Claude JB, Lang J.

Virology. 2012 Aug 1;429(2):91-8. doi: 10.1016/j.virol.2012.03.007. Epub 2012 Apr 25.

2.

Viremia and immunogenicity in nonhuman primates of a tetravalent yellow fever-dengue chimeric vaccine: genetic reconstructions, dose adjustment, and antibody responses against wild-type dengue virus isolates.

Guirakhoo F, Pugachev K, Arroyo J, Miller C, Zhang ZX, Weltzin R, Georgakopoulos K, Catalan J, Ocran S, Draper K, Monath TP.

Virology. 2002 Jun 20;298(1):146-59.

3.

Attenuation and immunogenicity of recombinant yellow fever 17D-dengue type 2 virus for rhesus monkeys.

Galler R, Marchevsky RS, Caride E, Almeida LF, Yamamura AM, Jabor AV, Motta MC, Bonaldo MC, Coutinho ES, Freire MS.

Braz J Med Biol Res. 2005 Dec;38(12):1835-46. Epub 2005 Nov 9.

4.

Construction, safety, and immunogenicity in nonhuman primates of a chimeric yellow fever-dengue virus tetravalent vaccine.

Guirakhoo F, Arroyo J, Pugachev KV, Miller C, Zhang ZX, Weltzin R, Georgakopoulos K, Catalan J, Ocran S, Soike K, Ratterree M, Monath TP.

J Virol. 2001 Aug;75(16):7290-304.

5.

Efficacy of a tetravalent chimeric dengue vaccine (DENVax) in Cynomolgus macaques.

Osorio JE, Brewoo JN, Silengo SJ, Arguello J, Moldovan IR, Tary-Lehmann M, Powell TD, Livengood JA, Kinney RM, Huang CY, Stinchcomb DT.

Am J Trop Med Hyg. 2011 Jun;84(6):978-87. doi: 10.4269/ajtmh.2011.10-0592.

6.

Safety and efficacy of chimeric yellow Fever-dengue virus tetravalent vaccine formulations in nonhuman primates.

Guirakhoo F, Pugachev K, Zhang Z, Myers G, Levenbook I, Draper K, Lang J, Ocran S, Mitchell F, Parsons M, Brown N, Brandler S, Fournier C, Barrere B, Rizvi F, Travassos A, Nichols R, Trent D, Monath T.

J Virol. 2004 May;78(9):4761-75.

7.

Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates.

Guirakhoo F, Weltzin R, Chambers TJ, Zhang ZX, Soike K, Ratterree M, Arroyo J, Georgakopoulos K, Catalan J, Monath TP.

J Virol. 2000 Jun;74(12):5477-85.

8.

Virus-like particle secretion and genotype-dependent immunogenicity of dengue virus serotype 2 DNA vaccine.

Galula JU, Shen WF, Chuang ST, Chang GJ, Chao DY.

J Virol. 2014 Sep;88(18):10813-30. doi: 10.1128/JVI.00810-14. Epub 2014 Jul 9.

9.

Genetic stability of a dengue vaccine based on chimeric yellow fever/dengue viruses.

Mantel N, Girerd Y, Geny C, Bernard I, Pontvianne J, Lang J, Barban V.

Vaccine. 2011 Sep 2;29(38):6629-35. doi: 10.1016/j.vaccine.2011.06.101. Epub 2011 Jul 13.

PMID:
21745519
10.

An adenovirus type 5 (AdV5) vector encoding an envelope domain III-based tetravalent antigen elicits immune responses against all four dengue viruses in the presence of prior AdV5 immunity.

Khanam S, Pilankatta R, Khanna N, Swaminathan S.

Vaccine. 2009 Oct 9;27(43):6011-21. doi: 10.1016/j.vaccine.2009.07.073. Epub 2009 Aug 7.

PMID:
19665609
11.

Live attenuated tetravalent dengue virus host range vaccine is immunogenic in African green monkeys following a single vaccination.

Briggs CM, Smith KM, Piper A, Huitt E, Spears CJ, Quiles M, Ribeiro M, Thomas ME, Brown DT, Hernandez R.

J Virol. 2014 Jun;88(12):6729-42. doi: 10.1128/JVI.00541-14. Epub 2014 Apr 2.

12.

Pediatric measles vaccine expressing a dengue tetravalent antigen elicits neutralizing antibodies against all four dengue viruses.

Brandler S, Ruffie C, Najburg V, Frenkiel MP, Bedouelle H, Despr├Ęs P, Tangy F.

Vaccine. 2010 Sep 24;28(41):6730-9. doi: 10.1016/j.vaccine.2010.07.073. Epub 2010 Aug 3.

PMID:
20688034
13.

Evaluation of tetravalent and conserved synthetic peptides vaccines derived from Dengue virus Envelope domain I and II.

Rocha RP, Livonesi MC, Fumagalli MJ, Rodrigues NF, da Costa LC, Dos Santos MC, de Oliveira Rocha ES, Kroon EG, Malaquias LC, Coelho LF.

Virus Res. 2014 Aug 8;188:122-7. doi: 10.1016/j.virusres.2014.04.009. Epub 2014 Apr 21.

PMID:
24768848
14.

Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses.

Guy B, Guirakhoo F, Barban V, Higgs S, Monath TP, Lang J.

Vaccine. 2010 Jan 8;28(3):632-49. doi: 10.1016/j.vaccine.2009.09.098. Epub 2009 Oct 4. Review.

PMID:
19808029
15.

Development of a novel DNA SynCon tetravalent dengue vaccine that elicits immune responses against four serotypes.

Ramanathan MP, Kuo YC, Selling BH, Li Q, Sardesai NY, Kim JJ, Weiner DB.

Vaccine. 2009 Oct 30;27(46):6444-53. doi: 10.1016/j.vaccine.2009.06.061. Epub 2009 Jul 4.

PMID:
19580892
16.

From research to phase III: preclinical, industrial and clinical development of the Sanofi Pasteur tetravalent dengue vaccine.

Guy B, Barrere B, Malinowski C, Saville M, Teyssou R, Lang J.

Vaccine. 2011 Sep 23;29(42):7229-41. doi: 10.1016/j.vaccine.2011.06.094. Epub 2011 Jul 13. Review.

PMID:
21745521
17.
18.

Immunogenicity and efficacy of chimeric dengue vaccine (DENVax) formulations in interferon-deficient AG129 mice.

Brewoo JN, Kinney RM, Powell TD, Arguello JJ, Silengo SJ, Partidos CD, Huang CY, Stinchcomb DT, Osorio JE.

Vaccine. 2012 Feb 14;30(8):1513-20. doi: 10.1016/j.vaccine.2011.11.072. Epub 2011 Dec 13.

PMID:
22178727
19.

Development of a recombinant tetravalent dengue virus vaccine: immunogenicity and efficacy studies in mice and monkeys.

Clements DE, Coller BA, Lieberman MM, Ogata S, Wang G, Harada KE, Putnak JR, Ivy JM, McDonell M, Bignami GS, Peters ID, Leung J, Weeks-Levy C, Nakano ET, Humphreys T.

Vaccine. 2010 Mar 24;28(15):2705-15. doi: 10.1016/j.vaccine.2010.01.022. Epub 2010 Jan 22.

20.

Virus-like particles displaying envelope domain III of dengue virus type 2 induce virus-specific antibody response in mice.

Arora U, Tyagi P, Swaminathan S, Khanna N.

Vaccine. 2013 Jan 30;31(6):873-8. doi: 10.1016/j.vaccine.2012.12.016. Epub 2012 Dec 20.

PMID:
23261049
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk